Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The 28th Annual San Antonio Breast Cancer Symposium (SABCS)

The 28th Annual San Antonio Breast Cancer Symposium (SABCS) Am J Cancer 2006; 5 (2): 137-139 MEETING REPORT 1175-6357/06/0002-0137/$39.95/0 © 2006 Adis Data Information BV. All rights reserved. The 28th Annual San Antonio Breast Cancer Symposium (SABCS) 8–11 December 2005, San Antonio, Texas, USA Melanie Sweetlove and Michelle Wilde Adis International Inc., Yardley, Pennsylvania, USA The San Antonio Breast Cancer Symposium (SABCS), held trials. Results were presented at this year’s SABCS by Professor every December in San Antonio, Texas, USA, is an international Walter Jonat (University of Kiel, Kiel, Germany). The three trials scientific symposium at which basic scientists and clinicians inter- involved a total of >4000 women who were randomized to receive act and exchange information about breast cancer. The 2005 either adjuvant tamoxifen for 2–3 years followed by anastrozole symposium was thought to be attended by approximately 7000 for the remaining 2–3 years or continuous tamoxifen for 5 years. delegates. The symposium involved five plenary sessions, four Compared with 5 years of continuous tamoxifen, switching to mini-symposia, 48 oral presentations, and nearly 700 posters. anastrozole reduced the risk of death by 29% (p < 0.05), the risk of recurrence or death by 45% (p < 0.001), and the risk of distant 1. Adjuvant Aromatase Inhibitors: A http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cancer Springer Journals

The 28th Annual San Antonio Breast Cancer Symposium (SABCS)

Loading next page...
 
/lp/springer-journals/the-28th-annual-san-antonio-breast-cancer-symposium-sabcs-wjelPZnmqN
Publisher
Springer Journals
Copyright
Copyright © 2006 by Adis Data Information BV
Subject
Pharmacy; Pharmacy
ISSN
1175-6357
DOI
10.2165/00024669-200605020-00007
Publisher site
See Article on Publisher Site

Abstract

Am J Cancer 2006; 5 (2): 137-139 MEETING REPORT 1175-6357/06/0002-0137/$39.95/0 © 2006 Adis Data Information BV. All rights reserved. The 28th Annual San Antonio Breast Cancer Symposium (SABCS) 8–11 December 2005, San Antonio, Texas, USA Melanie Sweetlove and Michelle Wilde Adis International Inc., Yardley, Pennsylvania, USA The San Antonio Breast Cancer Symposium (SABCS), held trials. Results were presented at this year’s SABCS by Professor every December in San Antonio, Texas, USA, is an international Walter Jonat (University of Kiel, Kiel, Germany). The three trials scientific symposium at which basic scientists and clinicians inter- involved a total of >4000 women who were randomized to receive act and exchange information about breast cancer. The 2005 either adjuvant tamoxifen for 2–3 years followed by anastrozole symposium was thought to be attended by approximately 7000 for the remaining 2–3 years or continuous tamoxifen for 5 years. delegates. The symposium involved five plenary sessions, four Compared with 5 years of continuous tamoxifen, switching to mini-symposia, 48 oral presentations, and nearly 700 posters. anastrozole reduced the risk of death by 29% (p < 0.05), the risk of recurrence or death by 45% (p < 0.001), and the risk of distant 1. Adjuvant Aromatase Inhibitors: A

Journal

American Journal of CancerSpringer Journals

Published: Aug 9, 2012

References